US4917895A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Transdermal drug delivery device
Assignee: Alza Corp
•
Filing: 1988-07-14
•
Granted: 1990-04-17
•
Expires: 2008-07-14
Abstract
Abstract A diffusional drug delivery device is described which can provide shelf life stability of the system components, elimination of the initial burst of drug and hence irritation, delayed onset of therapeutic effect and delivery of a therapeutic agent at an optimum rate. A metal layer and an activating means are inert when dry. Moisture activates the system whereby the activating means provides release of an eroding agent which erodes the metal layer through which the therapeutic agent diffuses and is subsequently delivered.
Inventors
- 👤 Eun S. Lee
- 👤 David Edgren
- 👤 Su I. Yum
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-09 18:50
CPC Classifications
A; A61; A61M; A61M35/00; A61K; A61K9/00; A61K9/70; A61K9/7023; A61K9/703; A61K9/7038; A61K9/7046; A61K9/7053; A61K9/7084
Claims Analysis
Total Claims: 19
Claim 1
Independent Claim
122 words
A controlled release medical device for delivery of a drug in a pre-determined delivery rate pattern to a biological environment comprising, in combination: reservoir means containing said drug having a surface through which the drug is released to the biological environment; a metal layer disposed between said reservoir means and the biological environment, wherein said metal layer in a first state is uneroded and, is substantially impermeable to the passage of said drug, and in a second stat is eroded and permeable to said drug; whereby substantially all of said drug must pass through said metal layer to reach the biological environment, and whereby the passage of drug to the biological environment by diffusion is impeded until the metal layer changes state.
Claim 2
Dependent Claim
122 words
A controlled release medical device for delivery of a drug in a pre-determined delivery rate pattern to a biological environment comprising, in combination: reservoir means containing said drug having a surface through which the drug is released to the biological environment; a metal layer disposed between said reservoir means and the biological environment, wherein said metal layer in a first state is uneroded and, is substantially impermeable to the passage of said drug, and in a second stat is eroded and permeable to said drug; whereby substantially all of said drug must pass through said metal layer to reach the biological environment, and whereby the passage of drug to the biological environment by diffusion is impeded until the metal layer changes state.
Claim 3
Independent Claim
14 words
The device of claim wherein said activating means is substantially free of said drug.
Claim 4
Dependent Claim
24 words
The device of claim 1 further comprising activating means by which said metal layer is changed from an uneroded state to an eroded state.
Claim 5
Dependent Claim
23 words
The device of claim 1 which further comprises: rate controlling means for controlling the rate at which drug is release from said reservoir.
Claim 6
Dependent Claim
60 words
The device of claim 4 wherein said metal layer, in the first uneroded state, is impermeable to the passage of drug in said reservoir means and permeable to the drug when in a second and eroded state and wherein said activating means is comprised of an eroding agent which converts said metal layer from its first to its second state.
Claim 7
Dependent Claim
25 words
The device of claim 5 which further comprises: rate controlling means for controlling the rate at which eroding agent is released from said activating means.
Claim 8
Dependent Claim
44 words
The device of claim 4 wherein said metal layer, in the first uneroded state, is impermeable to the passage of drug in said reservoir means and permeable to the drug when in a second and eroded state and wherein said activating means is sweat.
Claim 9
Dependent Claim
23 words
The device of claim 3 which further comprises: a plurality of metal layers, each disposed between a reservoir means and an activating means.
Claim 10
Dependent Claim
19 words
The device of claim 1 which further comprises: means for collecting any gas evolved as said metal changes state.
Claim 11
Dependent Claim
21 words
The device of claim 1 wherein drug is selected from the group consisting of nitroglycerin, benztropine, nicotine, secoverine, propranolol and timolol.
Claim 12
Dependent Claim
89 words
A medical device for the percutaneous administration of a drug, comprising: a backing layer impermeable to said drug; an drug reservoir comprised of said drug, disposed between said backing layer and the skin; an activating means disposed between said reservoir and the skin; a metal layer disposed between the reservoir and said activating means, wherein said metal layer is impermeable to the passage of said drug when un-eroded and permeable to said drug when eroded; and a means for maintaining said device in drug transferring relationship to the skin.
Claim 13
Dependent Claim
89 words
A medical device for the percutaneous administration of a drug, comprising: a backing layer impermeable to said drug; an drug reservoir comprised of said drug, disposed between said backing layer and the skin; an activating means disposed between said reservoir and the skin; a metal layer disposed between the reservoir and said activating means, wherein said metal layer is impermeable to the passage of said drug when un-eroded and permeable to said drug when eroded; and a means for maintaining said device in drug transferring relationship to the skin.
Claim 14
Dependent Claim
15 words
The device of claim 11 wherein said activating means is substantially free of said drug.
Claim 15
Dependent Claim
36 words
The device of claim 11 which further comprises: a rate controlling means for controlling the rate at which said drug is released from said drug reservoir when the device is placed in contact with the skin.
Claim 16
Dependent Claim
27 words
The device of claim 11 which further comprises: a rate controlling means for controlling the rate at which said eroding agent is released from said activating means.
Claim 17
Dependent Claim
22 words
The device of claim 11 wherein said drug is selected from the group consisting of nitroglycerin, benztropine, nicotine, secoverine, propranolol and timolol.
Claim 18
Independent Claim
71 words
A method of delivering a drug to a biological environment, comprising the steps of: placing a reservoir containing a drug to be delivered at the biological environment; and interposing a substantially drug free activating means and metal layer between the reservoir and the biological environment, wherein the metal layer in an un-eroded state is impermeable to the passage of said drug and in an eroded state is permeable to said drug.
Claim 19
Independent Claim
71 words
A method of delivering a drug to a biological environment, comprising the steps of: placing a reservoir containing a drug to be delivered at the biological environment; and interposing a substantially drug free activating means and metal layer between the reservoir and the biological environment, wherein the metal layer in an un-eroded state is impermeable to the passage of said drug and in an eroded state is permeable to said drug.
References Cited (Backward Citations)
US3598122B1
Cited
US3598122A
Cited
US3598123A
Cited
US3870593A
Cited
US4177256A
Cited
US3923939A
Cited
US4012221A
Cited
US4144317A
Cited
US4166111A
Cited
US4286592A
Cited
US4314557A
Cited
US4379454A
Cited
US4661105A
Cited
US4568343A
Cited
EP0197504A2
Cited
US4655766A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1993-04-16 | 1993-10-16 | 1994-04-17 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1997-04-16 | 1997-10-16 | 1998-04-17 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2001-04-16 | 2001-10-16 | 2002-04-17 | $7700.00 | Window Closed / Lapsed |